Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

Home > Science Hub > Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?
Back to the list

April 27, 2025

Eszter Papp, Pieter Mestdagh

You might also be interested by

CellTalk Blog

Rescuing a Pilot Study: How a Coordinated Response From CellCarta Kept a Critical Program on Track

April 14, 2026

More info

CellTalk Blog

Emerging Biomarkers Shaping the Next Generation of ADC Therapies

April 14, 2026

More info

CellTalk Blog

Meeting a Critical Deadline: How CellCarta’s California Laboratory Team Accelerated Assay Development and Clinical Testing to Deliver Ahead of Schedule

April 14, 2026

More info

Press Releases

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials

April 7, 2026

More info